Disseminated Toxoplasmosis in an Allogeneic Hematopoietic Stem Cell Transplant Recipient: A Case Report and Review of the Current Literature

Reactivation infections in hematopoietic stem cell transplants are mitigated by prophylactic regimens. Despite high rates of exposure, morbidity and mortality secondary to toxoplasmosis are limited to subsets of patients such as immunocompromised persons. We describe the first case of disseminated t...

Descripción completa

Detalles Bibliográficos
Autores principales: Baluch, Aliyah, Handley, Guy, Ludlow, Steven, Morrison, Austin, Velez, Ana, Rojas, Marcia C, Pasikhova, Yanina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569131/
https://www.ncbi.nlm.nih.gov/pubmed/36259018
http://dx.doi.org/10.7759/cureus.29185
Descripción
Sumario:Reactivation infections in hematopoietic stem cell transplants are mitigated by prophylactic regimens. Despite high rates of exposure, morbidity and mortality secondary to toxoplasmosis are limited to subsets of patients such as immunocompromised persons. We describe the first case of disseminated toxoplasmosis in a double umbilical cord blood transplant recipient.

Ejemplares similares